565 POSTER Activity of the anti-IGF-IR antibody CP-751,871 in combination with docetaxel as first-line treatment for castration resistant prostate cancer in a randomized Phase II trial
J.S. De Bono, D.P. Petrylak, E. Calvo, F. Saad, G.R. Hudes, M.M. Cooney, M.N. Pollak, D.B. Agus, S. Gillessen, J. ScrantonVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72499-6
File:
PDF, 69 KB
english, 2008